1673 studies found for:    "Hepatitis, Viral, Human"
Show Display Options
Rank Status Study
21 Completed Effect of Chronic Viral Hepatitis on the Pharmacokinetics of NRL972.
Condition: Hepatitis, Viral, Human
Intervention: Drug: NRL972
22 Completed Prospective Study of HIV Infection in Hemophiliacs
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections;   Blood Disease;   Hemophilia A;   Hepatitis, Viral, Human;   Blood Transfusion;   Cytomegalovirus Infections
23 Completed Delta Hepatitis and Liver Disease in Hemophiliacs
Conditions: Blood Disease;   Hepatitis, Viral, Human;   Hemophilia A;   Liver Diseases
24 Completed Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection
Condition: Hepatitis C Virus
Interventions: Drug: Sofosbuvir;   Drug: RBV
25 Completed Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C
Conditions: Hepatitis C, Chronic;   Liver Diseases;   Virus Diseases
Intervention: Drug: peginterferon alfa-2a and ribavirin
26 Completed
Has Results
Safety, Tolerability and Efficacy of 12-weeks of Sovaprevir, ACH-3102 and Ribavirin in Treatment-naive GT-1 HCV Subjects
Condition: Hepatitis C, Chronic
Interventions: Drug: Sovaprevir;   Drug: ACH-3102;   Drug: RBV;   Drug: Placebo
27 Active, not recruiting Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Condition: Hepatitis C Virus Infection
Interventions: Drug: GS-9857;   Drug: Placebo to match GS-9857;   Drug: SOF/GS-5816
28 Completed Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Ypeginterferon alfa-2b;   Drug: Peginterferon alfa-2a
29 Recruiting Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus
Condition: Hepatitis C
Interventions: Drug: DCV/ASV/BMS-791325;   Drug: DCV/ASV/BMS-791325 + RBV
30 Withdrawn Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients
Conditions: Hepatitis C, Chronic;   Liver Diseases;   Virus Diseases
31 Approved for marketing Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C
Condition: Post-transplant Hepatitis C
Interventions: Drug: Sofosbuvir;   Drug: Ribavirin;   Drug: Pegylated Interferon
32 Completed Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior Treatment
Condition: Chronic Hepatitis C
Intervention: Drug: Omega DUROS device
33 Completed A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.
Condition: Hepatitis C
Interventions: Drug: GSK2336805 10mg;   Drug: GSK2336805 30mg;   Drug: GSK2236805 100mg;   Drug: GSK2236805 200mg;   Drug: GSK2236805 10mg;   Drug: GSK2236805 dose to be determined up to 100mg;   Drug: GSK2236805 5mg;   Drug: GSK2236805 30mg
34 Recruiting Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions
Condition: Chronic Hepatitis C Infection
Interventions: Drug: Telaprevir;   Drug: Boceprevir
35 Recruiting Combination Therapy of Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B Patients
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir;   Drug: Interferon alfa-2b;   Drug: Interleukin 2;   Drug: Hepatitis B Vaccine
36 Completed A Study Evaluating Slow Response/Non-Rapid Response in Patients With Chronic Hepatitis C, Genotype 1, 2, 3 & 4 Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)
Condition: Hepatitis C, Chronic
Interventions: Drug: peginterferon alfa-2a [Pegasys];   Drug: ribavirin [Copegus]
37 Completed
Has Results
Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Relapser Genotype 2 Hepatitis C Infected Patients
Condition: Chronic Hepatitis C
Interventions: Drug: MP-424 (generic name:Telaprevir);   Drug: Ribavirin;   Drug: Peginterferon alfa-2b
38 Terminated HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection
Conditions: Hepatitis B;   Liver Transplantation
Interventions: Drug: HepeX-B;   Drug: Hepatitis B Immune Globulin (HBIg)
39 Unknown  To Study the Efficacy and Safety of Renessans in Chronic HCV Patients
Condition: Hepatitis C, Chronic
Interventions: Biological: RENESSANS , INTERFERON ALPHA 2b, Ribavirin;   Drug: Interferon Alfa-2b AND RIBAVIRIN;   Biological: RENESSANS
40 Completed The Effects of Honey, as a Dietary Supplement in Children With Hepatitis A
Condition: Hepatitis A
Interventions: Dietary Supplement: honey;   Dietary Supplement: molasses

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years